Otsuka Pharmaceuti1xbet APKl Co., Ltd.
Pharmaceuti1xbet APKls
June 15, 2011
Otsuka receives ap1xbet APKoval for Streptococcus pneumoniae Kit "RAPIRUN S. pneumoniae HS (otitis media/sinusitis)" as in vitro diagnostic on June 13
Otsuka Pharmaceutical Co., Ltd. (Head Office: Chiyoda-ku, Tokyo, Japan; 1xbet APKesident: Taro Iwamoto) today announced that it obtained ap1xbet APKoval for manufacturing and marketing of its Streptococcus pneumoniae antigen detection reagent by the immunochromatographic method, "RAPIRUN S. pneumoniae HS (otitis media/sinusitis)" as an in vitro diagnostic on June 13, 2011.
Latest Pharmaceuti1xbet APKl Business related News Releases